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SUMMARY
As the median age of deceased kidney donors rises, updated knowledge of
transplant outcomes from older deceased donors in differing donor–recipi-
ent age groups is required. Using ERA-EDTA Registry data we determined
survival outcomes of kidney allografts donated from the same older
deceased donor (55–70 years), and transplanted into one recipient younger
and one recipient of similar age to the donor. The recipient pairs were
divided into two groups: group 1; younger (median age: 52 years) and
older (60 years) and group 2; younger (41 years) and older (60 years). A
total of 1410 adults were transplanted during 2000–2007. Compared to the
older recipients, the mean number of functioning graft years at 10 years
was 6 months longer in the group 1 and group 2 younger recipients
(P < 0.001). Ten-year graft survival was 54% and 40% for the group 1
younger and older recipients, and 60% and 49% for the group 2 younger
and older recipients. Paired Cox regression analyses showed a lower risk of
graft failure (group 1 younger; adjusted relative risk [RRa]:0.57, 95%
CI:0.41–0.79, and group 2 younger; RRa:0.63, 95% CI:0.47–0.85) in
younger recipients. Outcomes from older deceased donor allografts trans-
planted into differing donor–recipient age groups are better than previ-
ously reported. These allografts remain a valuable transplant resource,
particularly for similar-aged recipients.
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Introduction
Global variations exist in the criteria for deceased donor
kidney allocation [1]. Some European deceased donor
kidney allocation schemes such as that of the UK,
Spain, France and Scandiatransplant take into consider-
ation the age difference between the donor and the
potential recipient, whereas others such as Eurotrans-
plant do not (for patients aged <65 years) [1]. Deceased
donor kidney allocation algorithms that are designed to
account for the age difference between the donor and
the potential recipient, will where possible allocate
younger kidneys to younger patients and older kidneys
to older patients [2]. However, the definition of an
acceptable donor–recipient age difference also varies
between allocation schemes, for example in Italy, a dif-
ference between the donor and recipient ages of less
than 15 years is preferred, whereas in Spain, a difference
of less than 10 years is preferred. Whilst allocation
schemes may take the donor–recipient age difference
into account, older donor kidneys are still being allo-
cated to patients of various ages.
The rationale of age matching is twofold; firstly by
matching the potential lifespan of the allograft with the
recipient, the organ is used efficiently. Secondly, young
recipients receiving old deceased donor kidneys have
been shown to have worse graft survival outcomes
including higher rates of graft failure from rejection
compared with young recipients receiving young
deceased donor kidneys [3–6]. However, many of these
previous studies were performed in the 1990s and early
2000s when the median age of both the donors and
recipients was lower, and graft survival outcomes were
worse.
Over the past two decades, the demand for trans-
plantable organs has resulted in an increased utilization
of older ‘marginal’ deceased donor kidneys. Subse-
quently, the median age of deceased kidney donors has
steadily increased [7, 8]. Within Northern Europe, the
median age of deceased kidney donors has risen from
approximately 35 years in the 1990s to approximately
55 years in 2015 [9, 10]. As the median age of deceased
kidney donors and their recipients is now approximately
55 years old, and transplant outcomes over the past two
decades have improved [11], updated patient and allo-
graft survival outcomes of kidneys transplanted from
deceased donors aged 55 years and over (i.e. above the
median deceased donor age) into recipients of differing
ages are required.
Using renal registry and transplant registry data from
nine European countries/regions, the aim of this study
was to quantify how long kidney allografts from older
deceased donors are expected to function for whilst
considering the donor–recipient age difference. Using a
paired analysis study design, we analysed patient and
allograft survival outcomes of two kidney allografts
donated from the same deceased donor aged between 55
and 70 years, and transplanted into two recipients of
differing ages; a recipient younger than the donor and a
recipient of similar age to the donor. This method
ensures that a kidney from the same donor is present in
both groups, thereby eliminating from the analyses the
effects of the donor factors on patient and graft out-
comes. Furthermore, we used a novel technique within
the kidney transplantation literature, the restricted mean
survival time, to quantify the mean difference in the
graft survival time between the groups [12].
Materials and methods
Data collection and study groups
Renal and transplant registries within nine European
countries or regions supplying data to the European
Renal Association–European Dialysis and Transplant
Association (ERA-EDTA) Registry were asked to
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identify transplant recipients fulfilling the specified
inclusion criteria. Where necessary additional data
required for the survival analyses were obtained from
the ERA-EDTA Registry database using a unique anon-
ymized patient identifier (see Table 1 for data sources).
The study cohort consisted of all patients aged
18 years and over who received their first kidney only
transplant between 2000 and 2007 from a deceased
donor aged between 55 and 70 years. As the median
deceased donor age in many European countries is
55 years, the age range 55–70 was specifically chosen to
reflect donors just above the average age of deceased
donation. Only cases where both kidneys from the same
deceased donor were transplanted into recipients of dif-
fering ages were considered. One transplant recipient
had to be within 5 years of the donor’s age (as these
recipients had a median age at transplantation above
the current median transplant age we called these recip-
ients the older recipients), and the second transplant
recipient from the same deceased donor had to be at
least 6 years or more younger than the donor. Given
the large range of the donor–recipient age gradient, that
is the difference in years between the donor and recipi-
ent ages, we subdivided the recipient pairs into two
groups; termed group 1 and group 2. The cut-off point
for the two groups was determined pre-analysis using
univariate Cox regression with restricted cubic regres-
sion splines analysis [13]. The groups were those ≥6 to
<13 years younger than the donor and their paired
older recipients (group 1) and those ≥13 years younger
than the donor and their paired older recipients (group
2). The chi-squared test and Mann–Whitney U-test
were used to compare the group characteristics.
Statistical analyses
Table 2 provides an overview of the different survival
analyses used in this article, that is the survival outcome
investigated and analysis method used, the starting
point, the event(s) of interest, competing event(s), cen-
soring observations and the potential confounders
accounted for in the multivariable analysis. In all of the
survival analyses, the date of kidney transplantation was
taken as the starting point of the analysis, and patients
were followed until the event of interest, a censored
observation and/or a competing event (see Table 2 for
details) or the end of the follow-up period (31 Decem-
ber 2013).
Restricted mean number of functioning graft years
The restricted mean survival is a way in which one
quantifies the mean survival of a treatment group mea-
sured up to a specific time point. It is computed as the
total area under the covariate-adjusted graft survival
curve up to a specific time point. By comparing the
mean survival of two groups, one obtains an assessment
of a treatment effect over a time interval [12]. This
method has the advantages of being relatively easy to
understand and can be used even in the presence of
nonproportional hazards [14]. We estimated the
restricted mean survival time of functioning graft years
(i.e. the number of years the allograft was functional
before loss secondary to graft failure or death with a
functioning graft). We repeated this process four times
with increasing follow-up times thereby obtaining the
mean graft survival time restricted to one, five, seven
Table 1. Additional data sources and number of recipients provided by country or region.
Country/Region
supplying data Data source(s)
Number of
recipients
Proportion
(%)
Austria Austrian dialysis and transplant registry 90 6.4
Basque country (Spain) Information unit about renal patients from the Basque Country 58 4.1
Catalonia (Spain) Catalan Renal Registry, Catalan Transplant Organization,
Health Department, Generalitat of Catalonia
182 12.9
Denmark Danish Renal Registry and Scandiatransplant 46 3.3
Finland Finnish Registry for Kidney Diseases and the Finnish Kidney
Transplant Registry
96 6.8
the Netherlands Dutch transplant foundation 138 9.8
Norway Norwegian Renal Registry 38 2.7
Sweden Swedish Renal Registry and Scandiatransplant 96 6.8
United Kingdom United Kingdom Renal Registry and UK Transplant Registry held
by NHS Blood and Transplant
666 47.2
Total 1410 100
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and 10 years of follow-up [12] (i.e. what was the aver-
age time the older donor kidneys were functional for in
one-, five-, seven- and 10-year follow-up). We adjusted
for important transplant-related parameters selected a
priori which could influence the functioning of the
graft, that is cold ischaemia time and human leucocyte
antigen (HLA) mismatch (favourable HLA-A, HLA-B
and HLA-DR mismatches: 000, 100, 010, 110 versus all
other mismatches). The SAS macro %RESMEAN was
used for this analysis [12].
Cumulative risk of graft failure
The cumulative incidence competing risk method was
used to estimate the unadjusted 10-year cumulative risk
of graft failure and death [15].
Relative risk of allograft failure and patient mortality
between younger and older recipients
Cox regression was used to estimate the relative risk of
graft failure (defined as graft loss from all causes or death
with a functioning graft) [16] and the relative all-cause
mortality risk between the older recipient group and the
corresponding younger recipient group. Furthermore,
Cox regression analysis was used to estimate the relative
risk of graft failure in which the competing event of death
was interpreted as a censored event [15] (henceforth ter-
med death-censored graft failure). All Cox regression
analyses were stratified by the donor pair, whereby the
patient or kidney allograft outcome of the older recipient
was directly compared to the patient or kidney allograft
outcome of the younger recipient from the same older
deceased donor. This removed any donor-associated fac-
tors from the analysis. Adjustments were made in a step-
wise manner. Firstly, we only adjusted for transplant-
related parameters which could influence graft survival,
that is cold ischaemia time and HLA mismatch. Secondly,
we added recipient factors which could influence graft
survival, that is, recipient sex, primary renal disease and
initial modality of renal replacement therapy.
A two-tailed P-value of less than 0.05 was considered
statistically significant. Analyses were performed using
SAS version 9.3 and R version 3.0.2.
Results
Baseline characteristics
In total 1410 paired kidney transplant recipients from
705 deceased donors aged between 55 and 70 years
were included in the study (Table 3). The recipients in
group 1 consisted of the younger recipients which were
within ≥6 to <13 years of the donor’s age (N = 336),
termed group 1 younger recipients and their corre-
sponding paired older recipients which were within
5 years of the same deceased donor’s age (N = 336),
termed group 1 older recipients; and the recipients in
group 2 consisted of the younger recipients which were
≥13 years younger than the donor (N = 369), termed
group 2 younger recipients and their corresponding
paired older recipients which were within 5 years of the
same donor’s age (N = 369), termed group 2 older
recipients.
Table 3 shows the baseline characteristics of the
recipient groups and the corresponding donor details.
The median donor–recipient age gradient was 8.1 years
(interquartile range [IQR] 7.0–10.0) for the group 1
younger recipients and 20 years (IQR 16.0 to 25.5) for
the group 2 younger recipients, whereas both groups of
paired older recipients were 0.9 years (IQR 2.0 to 3.0)
younger than the donor. The median age at kidney
transplantation was 52.0 years (IQR 49.0 to 56.3) for
the group 1 younger recipients and 40.7 years (IQR
34.0 to 45.0) for the group 2 younger recipients. The
median age of the older recipients in both groups was
60.0 years (IQR 57.0 to 64.0). At the time of donation,
the deceased donors donating to group 1 had a median
age of 61.0 years (IQR 58.0 to 65.0), and the deceased
donors donating to group 2 had a median age of
60.0 years (IQR 57.0 to 63.0).
Restricted mean number of functioning graft years
Table 4 shows the restricted mean number of function-
ing graft years, that is the number of years, the allo-
graft was functional before loss secondary to graft
failure or death with a functioning graft. Restricted to
1 year of follow-up, there was no difference in the
mean number of functioning graft years between the
younger and older recipients in group 1 and the
younger and older recipients in group 2. The difference
in the mean number of functioning graft years between
the younger and older recipients in both groups
increased with the duration of follow-up. By 10-year
follow-up, the difference in the mean number of func-
tioning graft years was 0.45 (95% confidence interval
[CI]: 0.18 to 0.72, i.e. 5.4 months) and 0.52 (95% CI:
0.27 to 0.77, i.e. 6.2 months longer) years longer in the
group 1 younger and group 2 younger recipients,
respectively, compared to their paired older recipients
(P < 0.001).
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Cumulative risk of graft failure
Figure 1 shows the 10-year cumulative risk of graft fail-
ure from all causes, that is graft failure and death with
a functioning graft for group 1 (upper panel) and group
2 (lower panel). The 10-year cumulative risk of graft
failure from all causes was 46% and 60% for the group
1 younger and older recipients, respectively, and 40%
and 51% for the group 2 younger and older recipients,
respectively.
Risk of allograft failure and patient survival
The risk of graft failure (defined as either graft failure
or death with a functioning graft) was 43% and 37%
lower in the group 1 and group 2 younger recipients,
respectively, relative to their paired older recipients
(Table 5). However, there was a similar risk of death-
censored graft failure in the group 1 and group 2
younger recipient groups compared to their paired older
recipients (Table 5). This reflected the fact that the risk
of patient death was considerably lower in both younger
recipient groups (Table 5).
Discussion
In this study, we have compared the survival outcomes
of kidney allografts from older deceased donors whilst
considering the donor–recipient age difference. We
examined the outcomes of kidney allografts from the
same deceased donor aged between 55 and 70 years
(median age of 60 years) transplanted into younger
recipients (group 1 with a median age of 52 years or
group 2 with a median age of 41 years) with the out-
comes when transplanted into an ‘older’ recipient (simi-
lar age as donor; median age of 60 years). By
performing a paired analysis, whereby a donor kidney is
present in the younger recipient group and in the corre-
sponding older recipient group, the effects of the donor
factors on patient and graft outcomes are essentially
eliminated from the analyses. In addition, this study
used a method novel in kidney transplantation, whereby
graft survival time was derived using the restricted mean
survival time. This technique provides easily inter-
pretable and comparable estimates of the number of
functioning graft years gained or lost by a treatment
over a specified time interval [12, 17]. Using the
restricted mean survival time method, we found that by
10 years of follow-up the mean number of functioning
graft years was 6 months longer in the younger recipi-
ents compared to the corresponding paired older T
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recipients. We found the 10-year graft survival from old
deceased donor kidneys to be 54% and 40% for the
group 1 younger and older recipients, respectively, and
60% and 49% for the group 2 younger and older recipi-
ents, respectively. This is much higher than the previ-
ously reported survival probabilities of 24% at 8 years
in recipients aged <55 years of allografts from deceased
donors aged ≥55 years [18] and consistent with other
studies showing improvements in graft survival within
European populations over time [11]. In contrast to
prior studies, we found a similar risk of death-censored
graft failure between the younger recipients compared
to the older recipients of old deceased donor kidneys.
The 10-year survival probabilities of older deceased
donor kidneys reported in this study are higher than
the previously quoted survival probabilities [4–6, 18].
For example, Lim et al. reported that for allografts from
donors aged ≥55 years, eight-year cumulative incidence
of death-censored graft failure was 22.3% and 16.4% in
recipients aged <55 years and ≥55 years, respectively
[5]. The majority of the previously quoted survival
probabilities arise from studies predominantly published
in the early 2000s using transplant data from the 1990s
[6]. Survival probabilities from deceased donors overall
(i.e. not stratified by donor age) have improved since
the 1990s [11]. This probably explains why our survival
probabilities from transplants that occurred between
2000 and 2007 are better.
When compared to the current overall European 10-
year deceased donor graft survival outcomes, our results
are worse. Our 10-year graft survival outcomes from
deceased donors aged between 55 and 70 years are
approximately 10% lower than the for overall European
deceased donor kidney transplant recipients trans-
planted in the same time period (10-year graft survival
probabilities of 71%, 65% and 54%, for a median recip-
ient transplant age of 41, 50 and 60 years, respectively –
unpublished data from the European Renal Associa-
tion–European Dialysis and Transplant Association
[ERA-EDTA] Registry). There are several physiological
changes in the older deceased donor kidney which may
explain in part, the lower graft survival probabilities
obtained in comparison with the overall graft survival
probabilities for European deceased donor kidney trans-
plant recipients. At the time of transplantation, older
deceased donor kidneys have been shown to have a
reduced number of nephrons [19] and evidence of age-
related pathology [20]. Furthermore, older deceased
donor kidneys are not able to mount an adequate repair
response following an injury [21]. These features also
render older deceased donor kidneys more susceptible
to the effects of longer cold ischaemia times [22].
Although these features in part explain the lower graft
survival outcomes we obtained in comparison with the
overall graft survival outcomes for European deceased
donor kidney transplant recipients, active efforts to
reduce cold ischaemia times, in addition to other
advances in the procurement of organs and in trans-
plant medicine overall may explain why these results are
higher than the historical results. Furthermore, in con-
trast to prior studies, we found a similar risk of death-
censored graft failure between younger recipients
compared with older recipients of old deceased donor
kidneys. The prior studies from the 1990s to 2000s
Figure 1 Ten-year cumulative risk of graft failure from all causes (i.e. graft failure and death) for the group 1 younger recipients and their
paired older recipients (upper panels a & b) and the group 2 younger recipients and their paired older recipients (lower panels c & d).
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often reported an inferior death-censored graft survival
in younger recipients of older donor kidneys [5, 18,
23]. As with the improvements in 10-year graft
survival, these new findings may also be explained by
developments in transplant medicine such as organ
procurement, transplant preservation and improved
immunosuppression medication. Despite the approxi-
mately 10% lower survival probability by 10-year fol-
low-up with older donor kidneys, one must remain
aware of the benefits of transplantation over dialysis,
including improved recipient quality of life and a lower
long-term financial burden.
It should be noted that the 10-year transplant
outcomes presented in this study are inevitably, a conse-
quence of donations which occurred approximately
10–15 years ago. Short-term transplant outcomes from
older deceased donors have improved in the last few
years [6, 24]. It is therefore also likely that the 10-year
transplant outcomes in a recipient of an older deceased
donor kidney transplanted today will be better than
what we present in this article.
The restricted mean survival time provides an alter-
native way with which to present time to an event/sur-
vival data. One of the benefits of this method is that the
result, often expressed in terms of years gained or lost
in comparison with an alternative treatment, is easily
interpretable for physicians and patients alike. Within
the kidney transplant literature, we identified one other
study using this method to examine kidney allograft
survival in older deceased donor kidneys [5]. Lim et al.
presented mean functioning graft years restricted to 16-
year follow-up of 7.1 years for old recipients
(≥55 years) of old donor kidneys (≥55 years) [5]. In
other words for sixteen-year follow-up, the mean func-
tioning graft survival time was 7 years, whereas the
mean functioning graft years in our study were between
7 and 7.5 years within a shorter follow-up of 10 years.
The cohort used in the study by Lim et al. was trans-
planted between 1991 and 2006, and therefore, the
inclusion of transplant outcomes from the 1990s is the
likely explanation for the poorer outcomes seen in their
study.
This study was not designed to compare survival out-
comes of young recipients receiving either young donor
kidneys or old donor kidneys. It is well documented
that survival outcomes are better for younger recipients
if they receive younger donor’s kidneys [25]. Further-
more, younger patients are likely to undergo retrans-
plantation; therefore, it is recommended that they
should not receive older donor kidneys given the
shorter graft survival time and associated risk ofT
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sensitization [6]. Nevertheless, as shown in this study,
kidney transplantations from older donors into younger
recipients do take place, as such, it is important to
quantify the survival outcomes of these allografts.
This study is subject to the traditional limitations
associated with observational studies, in particular the
inability to control for other potential confounding
factors. We lacked information on other donor factors
which contribute to the risk of graft loss such as
donor history of diabetes and cause of death. How-
ever, by performing a paired analysis, a kidney from
the same older deceased donor was present in the
young recipient and the older recipient group. We
thereby attempted to eliminate any donor-associated
factors which may have resulted in bias. However, one
cannot be completely sure that even though the donor
was the same, the kidneys were identical, for example
there may have been disparities in kidney size or the
presence of cysts between the two kidneys. Although
both groups of paired older recipients, that is those
paired to the younger recipients in group 1 or group
2 had the same median age, there were differences
between the groups; of those paired to the group 1
younger recipients (with a median age of 52 years),
only 3% had a preemptive transplant, compared to
9% of the older recipients paired to the group 2
younger recipients (with a median age of 41). More-
over, the graft survival at 10-year follow-up was lower
in the older recipients paired with the group 1
younger recipients compared with the older recipients
paired to the group 2 younger recipients (40% vs
49%, respectively). This may imply that clinicians
selectively allocate the ‘better quality’ older deceased
donor kidneys to the younger recipients and to the
healthier older recipients. Therefore, the study design
employed by this study to overcome the limited donor
details available to us may have introduced a selection
bias into the study. As such, these results cannot be
considered generalizable to all donor kidneys from
deceased donors aged between 55 and 70 years. We
did not have access to transplant factors known to
influence allograft outcomes such as the method of
graft preservation, panel reactive antibodies and
immunosuppression data, or information detailing epi-
sodes of delayed graft function or acute rejection
therefore we do not know how many episodes each
group experienced or the impact of these events. Nor
do we have an accurate record of the causes of graft
loss. Despite these limitations, there are a number of
strengths in this study including the paired donor
design, the relatively large cohort of recipients from a
nine European countries/regions and the reasonably
long follow-up time. Furthermore, the novel restricted
mean survival time method used in this study provides
easily interpretable estimates of the number of years
gained or lost or the percentage reduction of expected
restricted mean survival time.
Conclusion
The aim of this study was to quantify how long kidney
allografts from older deceased donors are expected to
function for whilst considering the donor–recipient age
difference. In line with kidney transplant outcomes
overall, 10-year graft survival probabilities from older
deceased donors have improved, though they remain
approximately 10% lower than the European average
kidney transplant survival probabilities. Compared to
the older recipients, the mean number of functioning
graft years at 10 years was 6 months longer in the
younger recipients. Older deceased donor kidneys
remain a useful transplant resource, particularly for
similar-aged recipients.
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